APA citáció

Milassin Ágnes, Fábián Anna, & Molnár Tamás. (2019). Switching from infliximab to biosimilar in inflammatory bowel disease.

Chicago Style (17th ed.) Citation

Milassin Ágnes, Fábián Anna, and Molnár Tamás. Switching from Infliximab to Biosimilar in Inflammatory Bowel Disease. 2019.

MLA idézés

Milassin Ágnes, et al. Switching from Infliximab to Biosimilar in Inflammatory Bowel Disease. 2019.